These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
527 related articles for article (PubMed ID: 27686042)
1. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B. Wang Y; Ke X; Voo ZX; Yap SSL; Yang C; Gao S; Liu S; Venkataraman S; Obuobi SAO; Khara JS; Yang YY; Ee PLR Acta Biomater; 2016 Dec; 46():211-220. PubMed ID: 27686042 [TBL] [Abstract][Full Text] [Related]
2. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity. Adams ML; Andes DR; Kwon GS Biomacromolecules; 2003; 4(3):750-7. PubMed ID: 12741794 [TBL] [Abstract][Full Text] [Related]
3. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B. Alvarez C; Shin DH; Kwon GS Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671 [TBL] [Abstract][Full Text] [Related]
4. A novel performing PEG-cholane nanoformulation for Amphotericin B delivery. Luengo-Alonso C; Torrado JJ; Ballesteros MP; Malfanti A; Bersani S; Salmaso S; Caliceti P Int J Pharm; 2015 Nov; 495(1):41-51. PubMed ID: 26319629 [TBL] [Abstract][Full Text] [Related]
5. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain. Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375 [TBL] [Abstract][Full Text] [Related]
6. "Click" amphotericin B in prodrug nanoformulations for enhanced systemic fungemia treatment. Guo D; Shi C; Suo L; Ji X; Yue H; Yuan D; Luo J J Control Release; 2024 Jun; 370():626-642. PubMed ID: 38734314 [TBL] [Abstract][Full Text] [Related]
7. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles. Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532 [TBL] [Abstract][Full Text] [Related]
8. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats. Radwan MA; AlQuadeib BT; Šiller L; Wright MC; Horrocks B Drug Deliv; 2017 Nov; 24(1):40-50. PubMed ID: 28155565 [TBL] [Abstract][Full Text] [Related]
9. The role of non-covalent interactions in anticancer drug loading and kinetic stability of polymeric micelles. Yang C; Attia AB; Tan JP; Ke X; Gao S; Hedrick JL; Yang YY Biomaterials; 2012 Apr; 33(10):2971-9. PubMed ID: 22244697 [TBL] [Abstract][Full Text] [Related]
10. Mixed micellar nanoparticle of amphotericin B and poly styrene-block-poly ethylene oxide reduces nephrotoxicity but retains antifungal activity. Han K; Miah MA; Shanmugam S; Yong CS; Choi HG; Kim JA; Yoo BK Arch Pharm Res; 2007 Oct; 30(10):1344-9. PubMed ID: 18038914 [TBL] [Abstract][Full Text] [Related]
11. In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(beta benzyl L aspartate) micelles. Yu BG; Okano T; Kataoka K; Sardari S; Kwon GS J Control Release; 1998 Dec; 56(1-3):285-91. PubMed ID: 9801451 [TBL] [Abstract][Full Text] [Related]
12. Amphotericin B/sterol co-loaded PEG-phospholipid micelles: effects of sterols on aggregation state and hemolytic activity of amphotericin B. Diezi TA; Kwon G Pharm Res; 2012 Jul; 29(7):1737-44. PubMed ID: 22130733 [TBL] [Abstract][Full Text] [Related]
13. The effect of kinetic stability on biodistribution and anti-tumor efficacy of drug-loaded biodegradable polymeric micelles. Attia AB; Yang C; Tan JP; Gao S; Williams DF; Hedrick JL; Yang YY Biomaterials; 2013 Apr; 34(12):3132-40. PubMed ID: 23380357 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen. Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections. Moreno-Rodríguez AC; Torrado-Durán S; Molero G; García-Rodríguez JJ; Torrado-Santiago S Int J Pharm; 2015 Oct; 494(1):17-22. PubMed ID: 26256151 [TBL] [Abstract][Full Text] [Related]
16. Lipoamino acid-based micelles as promising delivery vehicles for monomeric amphotericin B. Serafim C; Ferreira I; Rijo P; Pinheiro L; Faustino C; Calado A; Garcia-Rio L Int J Pharm; 2016 Jan; 497(1-2):23-35. PubMed ID: 26617315 [TBL] [Abstract][Full Text] [Related]
17. Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B. Song Z; Wen Y; Deng P; Teng F; Zhou F; Xu H; Feng S; Zhu L; Feng R Carbohydr Polym; 2019 Feb; 205():571-580. PubMed ID: 30446143 [TBL] [Abstract][Full Text] [Related]
18. Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length. Adams ML; Kwon GS J Control Release; 2003 Feb; 87(1-3):23-32. PubMed ID: 12618020 [TBL] [Abstract][Full Text] [Related]
19. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B. Yu BG; Okano T; Kataoka K; Kwon G J Control Release; 1998 Apr; 53(1-3):131-6. PubMed ID: 9741920 [TBL] [Abstract][Full Text] [Related]